Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 1, 2004, Pages 250-259

  Pinel, Sophie ^a   Barberi Heyob, Muriel ^a   Cohen Jonathan, Elizabeth ^d   Merlin, Jean Louis ^a   Delmas, Caroline ^d   Plenat, François ^b   Chastagner, Pascal ^c,e  

^a CENTRE ALEXIS VAUTRIN   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d INSTITUT CLAUDIUS REGAUD   (France)

^e HÔPITAL D ENFANTS   (France)

Author keywords

Fractionated radiotherapy; Hypoxic marker; Malignant glioma; pO2; Vascular density

Indexed keywords

BIOASSAY; BLOOD; CELLS; COLLAGEN; FRACTIONATION; HEMOGLOBIN; ONCOLOGY; OXYGEN; REDUCTION; TUMORS;

OXYGENATION; XENOGRAFTS;

GRAFTS;

ERYTHROPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; EVALUATION; GLIOMA; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TUMOR CELL; TUMOR GROWTH; XENOGRAFT;

ANIMALS; CELL HYPOXIA; ERYTHROPOIETIN, RECOMBINANT; GLIOMA; HEMOGLOBINS; HUMANS; MICE; MICE, NUDE; OXYGEN; RADIATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 11344268695     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.12.022     Document Type: Article

References (49)

1. Gray L.H., Conger A.D., Ebert M., et al. The concentration of oxygen in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 26:1953;638-648.
2. Cygler J., Klassen N.V., Ross C.K., et al. The survival of aerobic and anoxic human glioma and melanoma cells after irradiation at ultrahigh and clinical dose rates. Radiat Res. 140:1994;79-84.
3. Dachs G.U., Tozer G.M. Hypoxia modulated gene expression Angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer. 36:2000;1649-1660.
4. Overgaard J., Horsman M.R. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol. 6:1996;10-21.
5. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors A review. Cancer Res. 49:1989;6449-6465.
6. Fyles A.W., Milosevic M., Pintilie M., et al. Anemia, hypoxia and transfusion in patients with cervix cancer A review. Radiother Oncol. 57:2000;13-19.
7. Hill R.P., Bush R.S., Yeung P. The effect of anaemia on the fraction of hypoxic cells in an experimental tumour. Br J Radiol. 44:1971;299-304.
8. Becker A., Hansgen G., Bloching M., et al. Oxygenation of squamous cell carcinoma of the head and neck Comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys. 42:1998;35-41.
9. Becker A., Stadler P., Lavey R.S., et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 46:2000;459-466.
10. Dunst J., Kuhnt T., Strauss H.G., et al. Anemia in cervical cancers Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys. 56:2003;778-787.
11. Dunst J. Hemoglobin level and anemia in radiation oncology Prognostic impact and therapeutic implications. Semin Oncol. 27:2000;4-8. ; discussion 16-17.
12. Thomas G.M. Raising hemoglobin An opportunity for increasing survival? Oncology. 63:2002;19-28.
13. Harrison L.B., Shasha D., Homel P. Prevalence of anemia in cancer patients undergoing radiotherapy Prognostic significance and treatment. Oncology. 63:2002;11-18.
14. Kelleher D.K., Mattheinsen U., Thews O., et al. Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats. Cancer Res. 56:1996;4728-4734.
15. Thews O., Koenig R., Kelleher D.K., et al. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer. 78:1998;752-756.
16. Stuben G., Thews O., Pottgen C., et al. Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice. J Cancer Res Clin Oncol. 127:2001;346-350.
17. Stuben G., Pottgen C., Knuhmann K., et al. Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice. Int J Radiat Oncol Biol Phys. 55:2003;1358-1362.
18. Chastagner P., Pinel S., Merlin J.L., et al. Influence of overall treatment time of topotecan and radiotherapy administered alone or in combination in two xenografted human glioblastoma multiforme. Proc Am Soc Clin Oncol. 20:2001;237.
19. Chastagner P., Merlin J.L., Marchal C., et al. In vivo potentiation of radiation response by topotecan in human rhabdomyosarcoma xenografted into nude mice. Clin Cancer Res. 6:2000;3327-3333.
20. Coutier S., Bezdetnaya L.N., Foster T.H., et al. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice. Radiat Res. 158:2002;339-345.
21. Koch C.J., Evans S.M., Lord E.M. Oxygen dependence of cellular uptake of ef5[2-(2-nitro-1h-imidazol-1-yl)-n-(2, 2, 3, 3, 3-pentafluoropropyl)a cet amide] Analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Br J Cancer. 72:1995;869-874.
22. Cohen-Jonathan E., Evans S.M., Koch C.J., et al. The farnesyltransferase inhibitor l744, 832 reduces hypoxia in tumors expressing activated h-ras. Cancer Res. 61:2001;2289-2293.
23. Hockel M., Schlenger K., Aral B., et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
24. Nordsmark M., Hoyer M., Keller J., et al. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 35:1996;701-708.
25. Brizel D.M., Sibley G.S., Prosnitz L.R., et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 38:1997;285-289.
26. Fyles A.W., Milosevic M., Wong R., et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. [published erratum appears in Radiother Oncol 1999;50:371] Radiother Oncol. 48:1998;149-156.
27. Rampling R., Cruickshank G., Lewis A.D., et al. Direct measurement of po2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys. 29:1994;427-431.
28. Collingridge D.R., Piepmeier J.M., Rockwell S., et al. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol. 53:1999;127-131.
29. Levine E.A., Vijayakumar S. Blood transfusion in patients receiving radical radiotherapy A reappraisal. Onkologie. 16:1993;79-87.
30. Vijayakumar S., Roach M. 3rd, Wara W., et al. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy Preliminary results of a randomized, open-labeled, phase II trial. Int J Radiat Oncol Biol Phys. 26:1993;721-729.
31. Olsson A.M., Svensson J.H., Sundstrom J., et al. Erythropoietin treatment in metastatic breast cancer - effects on Hb, quality of life and need for transfusion. Acta Oncol. 41:2002;517-524.
32. Fallowfield L., Gagnon D., Zagari M., et al. Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy. Br J Cancer. 87:2002;1341-1353.
33. Joiner B., Hirst V.K., McKeown S.R., et al. The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse. Br J Cancer. 68:1993;720-726.
34. Dunst J. The use of epoetin alfa to increase and maintain hemoglobin levels during radiotherapy. Semin Oncol. 28:2001;42-48.
35. Littlewood T.J. The impact of hemoglobin levels on treatment outcomes in patients with cancer. Semin Oncol. 28:2001;49-53.
36. Anagnostou A., Lee E.S., Kessimian N., et al. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A. 87:1990;5978-5982.
37. Ribatti D., Presta M., Vacca A., et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood. 93:1999;2627-2636.
38. Yasuda Y., Masuda S., Chikuma M., et al. Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem. 273:1998;25381-25387.
39. Acs G., Acs P., Beckwith S.M., et al. Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res. 61:2001;3561-3565.
40. Thomlinson R.H., Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 9:1955;539-549.
41. Brown J.M., Yu N.Y. Cytotoxicity of misonidazole in vivo under conditions of prolonged contact of drug with the tumour cells. Br J Radiol. 52:1979;893-896.
42. Chaplin D.J., Olive P.L., Durand R.E. Intermittent blood flow in a murine tumor Radiobiological effects. Cancer Res. 47:1987;597-601.
43. Zywietz F., Reeker W., Kochs E. Tumor oxygenation in a transplanted rat rhabdomyosarcoma during fractionated irradiation. Int J Radiat Oncol Biol Phys. 32:1995;1391-1400.
44. Brizel D.M., Dodge R.K., Clough R.W., et al. Oxygenation of head and neck cancer Changes during radiotherapy and impact on treatment outcome. Radiother Oncol. 53:1999;113-117.
45. Stuben G., Thews O., Pottgen C., et al. Tumour oxygenation during fractionated radiotherapy - comparison with size-matched controls. Acta Oncol. 38:1999;209-213.
46. Brown J.M. The hypoxic cell A target for selective cancer therapy - eighteenth Bruce F. Cain memorial award lecture. Cancer Res. 59:1999;5863-5870.
47. Yasuda Y., Musha T., Tanaka H., et al. Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice. Br J Cancer. 84:2001;836-843.
48. Yasuda Y., Fujita Y., Matsuo T., et al. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis. 24:2003;1021-1029.
49. Littlewood T.J., Cella D., Nortier J.W. Erythropoietin improves quality of life. Lancet Oncol. 3:2002;459-460.